The recipient in Changsha, the capital of Hunan Province, became the first man on the Chinese mainland to receive the HPV vaccine, after U.S. pharmaceutical giant Merck announced its quadrivalent HPV ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...

US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...

Summit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck's (NYSE:MRK) dominance in lung cancer, won ...

The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human ...

The two suspected cases are both children aged seven and 14 years and were treated in the outpatient department of a private ...

Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...

UBS analyst Trung Huynh lowered the firm’s price target on Merck (MRK) to $120 from $125 and keeps a Buy rating on the shares as part of a ...

Merck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration ...